PT99142A - Processo para a preparacao de pro-medicamentos de sertindole e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de pro-medicamentos de sertindole e de composicoes farmaceuticas que os contem

Info

Publication number
PT99142A
PT99142A PT99142A PT9914291A PT99142A PT 99142 A PT99142 A PT 99142A PT 99142 A PT99142 A PT 99142A PT 9914291 A PT9914291 A PT 9914291A PT 99142 A PT99142 A PT 99142A
Authority
PT
Portugal
Prior art keywords
sertindole
group
medicines
pro
preparation
Prior art date
Application number
PT99142A
Other languages
English (en)
Other versions
PT99142B (pt
Inventor
Henrik Pedersen
Jens Kristian Perregaard
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of PT99142A publication Critical patent/PT99142A/pt
Publication of PT99142B publication Critical patent/PT99142B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
PT99142A 1990-10-03 1991-10-02 Processo para a preparacao de pro-medicamentos de sertindole e de composicoes farmaceuticas que os contem PT99142B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK238190A DK238190D0 (da) 1990-10-03 1990-10-03 Depotderivater

Publications (2)

Publication Number Publication Date
PT99142A true PT99142A (pt) 1994-02-28
PT99142B PT99142B (pt) 1999-04-30

Family

ID=8111993

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99142A PT99142B (pt) 1990-10-03 1991-10-02 Processo para a preparacao de pro-medicamentos de sertindole e de composicoes farmaceuticas que os contem

Country Status (21)

Country Link
US (1) US5428036A (pt)
EP (1) EP0592433B1 (pt)
JP (1) JP3100980B2 (pt)
KR (1) KR100212430B1 (pt)
AT (1) ATE175964T1 (pt)
AU (1) AU652783B2 (pt)
CA (1) CA2093433C (pt)
DE (1) DE69130803T2 (pt)
DK (2) DK238190D0 (pt)
ES (1) ES2125870T3 (pt)
FI (1) FI102679B1 (pt)
GR (1) GR3029399T3 (pt)
HK (1) HK1009273A1 (pt)
IE (1) IE913384A1 (pt)
IL (1) IL99652A (pt)
NO (1) NO301475B1 (pt)
NZ (1) NZ240051A (pt)
PH (1) PH30129A (pt)
PT (1) PT99142B (pt)
WO (1) WO1992006089A1 (pt)
ZA (1) ZA917881B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK206591D0 (da) * 1991-12-23 1991-12-23 Lundbeck & Co As H Behandling af psykoser
JPH0625964U (ja) * 1992-05-25 1994-04-08 ミクロン機器株式会社 通信機能付きコインカウンタ及び有料装置
US6489341B1 (en) 1999-06-02 2002-12-03 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
US7816398B2 (en) 2001-03-23 2010-10-19 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
JP2005500988A (ja) * 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
US20100168197A1 (en) * 2007-02-28 2010-07-01 Naresh Kumar Muscarinic receptor antagonists
WO2010151711A1 (en) 2009-06-25 2010-12-29 Alkermes, Inc. Prodrugs of nh-acidic compounds
HRP20171415T4 (hr) 2009-06-25 2023-03-03 Alkermes Pharma Ireland Limited Heterociklični spojevi za liječenje neuroloških i psiholoških poremećaja
EP2585066B1 (en) * 2010-06-24 2018-09-26 Alkermes Pharma Ireland Limited Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
JP7384812B2 (ja) 2018-03-05 2023-11-21 アルカームス ファーマ アイルランド リミテッド アリピプラゾール投与戦略

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3408356A (en) * 1965-08-31 1968-10-29 Squibb & Sons Inc Long chain esters of 4'-fluoro-4-[4-hydroxy-4-(alpha, alpha, alpha-trifluorotolyl)piperi-dino]butyrophenone and the like
US4038305A (en) * 1972-03-20 1977-07-26 Aktieselskabet Grindstedvaerket Cyclopentenone derivatives
GB1469108A (en) * 1973-06-25 1977-03-30 Kefalas As Thiaxanthene derivative
JPS568318A (en) * 1979-06-28 1981-01-28 Janssen Pharmaceutica Nv Non oral long acting composition of haloperidol and bromperidol derivative
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8621892D0 (en) * 1986-09-11 1986-10-15 Lundbeck & Co As H Organic compound
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DE3921886A1 (de) * 1989-07-04 1991-01-17 Wolfgang Mohr Vorrichtung zum schneiden von gestapeltem, blattfoermigen gut

Also Published As

Publication number Publication date
CA2093433A1 (en) 1992-04-04
DK238190D0 (da) 1990-10-03
FI931472A (fi) 1993-04-01
KR100212430B1 (ko) 1999-08-02
IL99652A (en) 1997-04-15
ZA917881B (en) 1992-07-29
JPH06501939A (ja) 1994-03-03
NO301475B1 (no) 1997-11-03
KR930702335A (ko) 1993-09-08
CA2093433C (en) 2000-11-21
NO931219D0 (no) 1993-03-31
FI931472A0 (fi) 1993-04-01
FI102679B (fi) 1999-01-29
NZ240051A (en) 1993-05-26
DK0592433T3 (da) 1999-09-13
PH30129A (en) 1997-01-21
FI102679B1 (fi) 1999-01-29
JP3100980B2 (ja) 2000-10-23
GR3029399T3 (en) 1999-05-28
EP0592433B1 (en) 1999-01-20
DE69130803T2 (de) 1999-08-19
IL99652A0 (en) 1992-08-18
IE913384A1 (en) 1992-04-08
WO1992006089A1 (en) 1992-04-16
DE69130803D1 (de) 1999-03-04
EP0592433A1 (en) 1994-04-20
US5428036A (en) 1995-06-27
ATE175964T1 (de) 1999-02-15
HK1009273A1 (en) 1999-05-28
AU652783B2 (en) 1994-09-08
NO931219L (no) 1993-04-01
PT99142B (pt) 1999-04-30
ES2125870T3 (es) 1999-03-16
AU8710491A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
PT99142A (pt) Processo para a preparacao de pro-medicamentos de sertindole e de composicoes farmaceuticas que os contem
ATE25251T1 (de) Anti srs-a carbonsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische formulierungen.
MX9300031A (es) Derivados de piperazina, procedimiento para su preparacion y composicion farmaucetica que los contiene.
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
ATE59033T1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
DE69628750D1 (de) Neue antivirale, homocarbozklische nukleosidderivate von substituierten pyrimidindionen, verfahren zu ihrer herstellung und zusammensetzungen, die diese als aktiven bestandteil enthalten
AR001767A1 (es) Derivados de ciclolignanos utiles como inmunosupresores composiciones farmaceuticas que los contienen y procedimiento para preparar dichos derivados
KR890701584A (ko) 20, 21-디노르에비나메닌의 신규 치환 유도체, 그의 제조 방법 및 이 방법으로 얻는 신규 중간체, 약제로서의 그의 용도 및 그를 함유하는 제약 조성물
PT1047664E (pt) Novos compostos triciclicos processo para a sua preparacao e as composicoes farmaceuticas que os contem
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES8301919A1 (es) Procedimiento para preparar derivados de indano
ATE29251T1 (de) Aminopyridincarbonsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE23150T1 (de) Aminoethoxybenzylalkohol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE56438T1 (de) 1-(cyclohexyl>-3,4-di-(hydro>isochinolinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
GB949732A (en) New piperidine derivatives and process for their production
KR920017661A (ko) 진행성 당뇨병의 진전 억제용 제약 조성물
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.
GB889660A (en) Morphanthridine compounds
HUT53638A (en) Process for producing 15-amino-substituted 20,21-dinoreburnamenie derivatives and pharmaceutical compositions containing them
ES8200112A1 (es) Un procedimiento para la preparacion de un derivado del aci do clavulanico.
KR970010737A (ko) 2-(4-아세틸아미노벤조일아미노)벤즈아미드 유도체, 그 제조방법 및 그를 함유하는 진통제

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19931029

FG3A Patent granted, date of granting

Effective date: 19990111

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20090713